中西医结合肝病杂志
中西醫結閤肝病雜誌
중서의결합간병잡지
CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE ON LIVER DISEASES
2014年
4期
220-222
,共3页
杨将领%王建丽%陈海平%张斌
楊將領%王建麗%陳海平%張斌
양장령%왕건려%진해평%장빈
健肝方/治疗应用%非酒精性脂肪性肝炎%中药疗法
健肝方/治療應用%非酒精性脂肪性肝炎%中藥療法
건간방/치료응용%비주정성지방성간염%중약요법
Jiangan formula/therapeutic application%nonalcoholic steatohepatitis%traditional Chinese medicine therapy
目的:观察健肝方治疗非酒精性脂肪性肝炎( NASH)的临床疗效。方法:将72例NASH患者随机分为治疗组36例和对照组36例,治疗组患者口服健肝方,对照组患者口服水飞蓟素胶囊,两组疗程均为6个月。分别在治疗3个月、6个月时观察两组患者症状改善情况及肝功能、血脂以及肝/脾CT比值的变化。结果:治疗组总有效率为80.6%,对照组为69.4%,治疗组优于对照组( P<0.05)。治疗6个月时治疗组患者ALT、 AST、 TC、 HDL-C、肝/脾CT比值的改善优于对照组(P<0.05)。结论:健肝方治疗NASH具有良好的临床疗效,可明显改善患者临床症候群,降低肝功能、血脂水平,改善肝/脾CT比值。
目的:觀察健肝方治療非酒精性脂肪性肝炎( NASH)的臨床療效。方法:將72例NASH患者隨機分為治療組36例和對照組36例,治療組患者口服健肝方,對照組患者口服水飛薊素膠囊,兩組療程均為6箇月。分彆在治療3箇月、6箇月時觀察兩組患者癥狀改善情況及肝功能、血脂以及肝/脾CT比值的變化。結果:治療組總有效率為80.6%,對照組為69.4%,治療組優于對照組( P<0.05)。治療6箇月時治療組患者ALT、 AST、 TC、 HDL-C、肝/脾CT比值的改善優于對照組(P<0.05)。結論:健肝方治療NASH具有良好的臨床療效,可明顯改善患者臨床癥候群,降低肝功能、血脂水平,改善肝/脾CT比值。
목적:관찰건간방치료비주정성지방성간염( NASH)적림상료효。방법:장72례NASH환자수궤분위치료조36례화대조조36례,치료조환자구복건간방,대조조환자구복수비계소효낭,량조료정균위6개월。분별재치료3개월、6개월시관찰량조환자증상개선정황급간공능、혈지이급간/비CT비치적변화。결과:치료조총유효솔위80.6%,대조조위69.4%,치료조우우대조조( P<0.05)。치료6개월시치료조환자ALT、 AST、 TC、 HDL-C、간/비CT비치적개선우우대조조(P<0.05)。결론:건간방치료NASH구유량호적림상료효,가명현개선환자림상증후군,강저간공능、혈지수평,개선간/비CT비치。
Objective: To observe the clinical curative effect of Jiangan formula on the rehabilitation treatment of nonalco -holic fatty liver disease.Methods: Seventy two patients were randomly divided into treatment group and control group on aver-age, the treatment group given the 6 months of Jiangan formula treatment , the control group given 6 months of silymarin capsule treatment.Observe both of two groups ’ improvements of the symptoms , the liver function , blood lipid and liver/spleen CT ratio after 3 months and 6 months treatment respectively.The patients of two groups were suitable to strengthen physical exercise and control diet during treatment.Results: The total effective rates of treatment group and control group were 80.6%and 69.4%re-spectively, the treatment group was better than that of control group (P<0.05) .After treatment for 6 months, the changes of treatment group’ s ALT, AST, TC, HDL-C level of liver/spleen CT ratio was better than that of control group (P<0.05).Conclusion: There is a better clinical curative effect of Jiangan formula on the rehabilitation treatment of nonalcoholic fatty liver disease, which can significantly improve the patients'TCM symptoms, liver function, blood fat, liver/spleen CT ratio.